Foghorn Therapeutics Appoints Michael LaCascia as Chief Legal Officer
CAMBRIDGE, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Foghorn Therapeutics Inc. (Nasdaq: FHTX), a company pioneering the discovery and development...
Staff
Agenus and Dr. Steven O’Day to Participate in Panels at the Virtual SITC 2020 Immuno-Oncology Event Hosted by B. Riley
LEXINGTON, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of...
Neuropathix, Inc. Reveals Visual Identity to Coincide With Its Mission for Socially Responsible Pain Management
DOYLESTOWN, Pa., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Neuropathix, Inc. ("Neuropathix" or the “Company”) (OTCQB: NPTX), formerly Kannalife, Inc., is...
Generex Biotechnology Announces Interview with Richard Purcell EVP of R&D on the Yo! Dr.Yo Show with an Update on the Ii-Key COVID Vaccine Program
Livestream Interview on Friday November 13 at 2 PM EST MIRAMAR, Fla., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Generex Biotechnology...
Atreca Reports Third Quarter 2020 Financial Results and Recent Corporate Developments
SOUTH SAN FRANCISCO, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused...
Allogene Therapeutics Announces November and December 2020 Virtual Investor Conference Participation
SOUTH SAN FRANCISCO, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering...
Primo Nutraceuticals Inc. Enters intoa Binding LOI to acquire 100% of the Assets of Full Spectrum Biosciences Inc.
VANCOUVER, British Columbia, Nov. 12, 2020 (GLOBE NEWSWIRE) -- PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF ) (FSE: 8BV) (DEU:...
Aligos Therapeutics is awarded €1.8M VLAIO grant to advance chronic hepatitis B research
SOUTH SAN FRANCISCO, Calif. and LEUVEN, Belgium, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical...
Resverlogix Announces Publication in High-impact, Peer-reviewed Journal, Clinical Epigenetics
Publication Explores the Beneficial Effects of Apabetalone on the Immune Cells of Diabetic Patients Event Reminder: Multiple Presentations on Apabetalone...
eFFECTOR Announces Dosing of First Breast Cancer Patient with Tomivosertib in Combination with Chemotherapy Through a Grant from Stand Up To Cancer® (SU2C) Canada
SAN DIEGO, Nov. 12, 2020 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulation...
Better Choice Launches New Corporate and Store Websites Designed to Meet Increasing Consumer Demand and Expand Investor Awareness
NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Better Choice Company (OTCQB: BTTR) (“Better Choice”), an animal health and wellness...
Immunovant Reports Financial Results for the Quarter and Six Months Ended September 30, 2020
Company Ended the Quarter With Cash of Approximately $444 Million NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Immunovant, Inc....
Biotricity Launches Biocare Telemed for Safe and Convenient Remote Patient Care
Secure HIPAA compliant technology for at-risk chronic care patients REDWOOD CITY, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc....
Harmony Biosciences Reports Third Quarter 2020 Financial Results and Business Updates
WAKIX®(pitolisant) Total Revenue of $45.6 Million for Third Quarter of 2020 Differentiated Product Profile Aligns with Unmet Medical Need On...
Alimera Sciences Announces Real-World Clinical Data for ILUVIEN® to be Presented at the American Academy of Ophthalmology 2020 Virtual Conference
ATLANTA, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a leader in the commercialization and development...
Clinical Evidence Shows that the FlareHawk® Multiplanar Expandable Cage Delivers Favorable Fusion and Patient Outcomes Demonstrating Conformity to Endplate Anatomy with No Observed Device Subsidence
IJSS-published peer-reviewed studies demonstrate the device’s respect for neural anatomy and conformability to bony endplates through Adaptive Geometry™ PALM BEACH...
PetVivo Holdings, Inc. Announces Sponsored Research Agreement with Colorado State University for Osteoarthritis Treatment Study.
PetVivo Holdings, Inc. The treatment of osteoarthritis in canines through the administration of PetVivo’s proprietary medical device, KUSH®. MINNEAPOLIS, Nov....
Neil Medical Group Selects TRHC’s DoseMeRx to Provide Precision Dosing Services For Long-term Care Facilities
The Contract Spans Neil Medical Group’s Network of Long-Term Care & Assisted Living Facilities Across the Southeastern United States MOORESTOWN,...
American Cannabis Company, Inc. Announces Approval of Operator’s License by Colorado’s Marijuana Enforcement Division (MED)
DENVER, CO, Nov. 12, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC” or “Company”),...
Replimune to Participate at the SVB Leerink Oncology 1×1 Day
WOBURN, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Replimune Group Inc. (Nasdaq: REPL), a biotechnology company developing oncolytic immuno-gene therapies...